Author

Eyal Schiff

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Alejandro A. SchäfferiD· 1 shared Andrea Borghese ApoloiD· 1 shared Antonios Papanicolau‐SengosiD· 1 shared Boris Temkin· 1 shared Danh-Tai HoangiD· 1 shared Dejan JuriciD· 1 shared Doreen S. Ben-ZviiD· 1 shared Eden Maimon· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Alejandro A. SchäfferORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome

Gal Dinstag, Eldad David Shulman, Efrat Elis, Doreen S. Ben-Zvi, Omer Tirosh, Eden Maimon, Isaac Meilijson, Emmanuel Elalouf, Boris Temkin, Philipp Vitkovsky, Eyal Schiff, Danh-Tai Hoang, Sanju Sinha, Nishanth Ulhas Nair, Joo Sang Lee, , Ranit Aharonov

ENLIGHT predicts patient response to targeted and immunotherapies using tumor transcriptomes without prior treatment response data, showing better accuracy than existing transcriptomics-based signatures.

Med · Dec 12, 2022Peer-reviewedBioinformatics